COMPARATIVE ANALYSIS OF IMMUNOLOGICAL DIAGNOSTIC TESTS IN CHILDREN LIVING IN HOUSEHOLD TUBERCULOSIS FOCI
Abstract
Objective: To evaluate and compare the results of immunological diagnostic tests in children living in family tuberculosis hotspots based on data from the Samarkand region. Materials and methods: The study was conducted from 2021 to 2024. It included 670 children aged 4 to 12 years who had received the BCG vaccine and had a positive Mantoux test with 2 TU of PPD-L tuberculin. All children underwent testing with the Diaskintest preparation as well as the Quantiferon test. Results: Based on the comprehensive examination results, children were divided into the following groups: Group I - 273 healthy children (40.7%); Group II - 120 (17.9%) patients with latent tuberculosis infection (LTI); Group III - 277 children with active pulmonary tuberculosis (41.4%). Discussion: The sensitivity results to PPD-L tuberculin with 2 TU do not provide sufficiently reliable information for differentiating between patients with LTI and active forms of tuberculosis in children. The high results of the Mantu test in the cohort of healthy children (23.8%) are noteworthy, while the average results of the tuberculin test with 2 TB were recorded in 53.4% of cases in the group of children with active forms of tuberculosis, as well as in 52.5% of the LTI cohort of children. One in five children with a difference in the positive results of the ATR test with a simultaneous negative result of the QFT test were classified as frequently and long-term ill children and suffered from ENT pathology. More than half of these children had a history of allergic pathology (54.5%) and metabolic disorders in the form of overweight and obesity (63.6%). Conclusions: in cases where the results of the ATP test are interpreted as false positive, it is necessary to use alternative methods - IGRA tests (Quantiferon).
About the Authors
List of references
Кисличкин Н.Н., Ленхерр-Ильина Т.В., Красильников И.В. Диагностика туберкулеза. Туберкулин и группа препаратов на основе белков ESAT-6/CFP-10. Инфекционные болезни 2016;14(1):48–54. [Kislichkin N.N., Lenxerr-Ilina T.V., Krasilnikov I.V. Diagnosis of tuberculosis. Tuberculin and group oа drugs on basis of ESAT-6/CFP-10 proteins. Infeksionnie bolezni 2016;14(1):48–54 (in Russ)] DOI: https://doi.org/10.20953/1729-9225-2016-1-48-54.
Лозовская М.Э., Захарова О.П., Яровая Ю.А., Никифоренко Н.А., Курова А.С. Двухлетнее применение пробы с аллергеном туберкулезным рекомбинантным для выявления туберкулеза у детей в Санкт-Петербурге. Вестник новгородского государственного университета 2020;3(119):43-46. [Lozovskaya M.E., Zaxarova O.P., Yarovaya Yu.A., Nikiforenko N.A., Kurova A.S. Two-year use of a tuberculosis-recombinant allergen test to detect tuberculosis in children in Saint Petersburg. Vestnik novgorodskogo gosudarstvennogo universiteta 2020;3(119):43-46 (in Russ)] DOI: https://doi.org/10.34680/2076-8052.2020.3(119).43-46.
Овсянкина Е.С. Актуальные проблемы туберкулеза у подростков из очагов туберкулезной инфекции. Туберкулез и болезни легких 2018;96(6):17-20. [Ovsyankina Ye.S. Topical problems of tuberculosis in adolescents from tuberculosis infection centers. Tuberkulez i bolezni legkix 2018;96(6):17-20 (in Russ)] DOI: https://doi.org/10.21292/2075-1230-2018-96-6-17-20.
Салова А.Л., Челнокова О.Г., Мозжухина Л.И., Борисова Е.В., Афанасенко О.А., Миначенкова М.В., Ясонова Д.А. Факторы риска развития латентной туберкулезной инфекции у детей // Современные проблемы науки и образования. 2024. №6. [Salova A.L., Chelnokova O.G., Mozjuxina L.I., Borisova Ye.V., Afanasenko O.A., Minachenkova M.V., Yasonova D.A. Risk factors for developing latent tuberculosis infection in children // Sovremennыe problemы nauki i obrazovaniya. 2024;(6) (in Russ)]
URL: https://science-education.ru/ru/article/view?id=33826 (Accessed 24.01.2025).
Уфимцева Е.Г. Клетки с микобактериями в гранулематозных образованиях мышей на латентной стадии туберкулезной инфекции в культуре exvivo. Инфекция и иммунитет 2018;3(3):229–234. [Ufimseva Ye.G. Cells with mycobacteria in the granulomatous formations of mice at the latent stage of tuberculous infection in exvivo culture. Infeksiya i immunitet 2018;3(3):229–234. (in Russ)]. URL: https://rucont.ru/efd/437068 (Accessed 24.01.2025)
Федеральные клинические рекомендации по диагностике и лечению латентной туберкулезной инфекции у детей. Москва; Здоровье человека, 2024;36 [Federal clinical guidelines for the diagnosis and treatment of latent tuberculosis infection in children.. Moscow; Zdorove cheloveka, 2024;36 (in Russ)].
Ahmad R, Xie L, Pyle M, Suarez MF, Broger T, Steinberg D, et al. A rapid triage test for active pulmonary tuberculosis in adult patients with persistent cough. Sciene Translational Medicine. 2019;11(115):28-34. https://doi.org/10.1126/SCITRANSLMED.AAW8287.
Cremoni M, Allouche J, Graça D, Zorzi K, Fernandez C, Teisseyre M, et al. Low baseline IFN-γ response could predict hospitalization in COVID-19 patients. Front Immunol 2022;13. http://dx.doi.org/10.3389/fimmu.2022.953502.
Moreira-Teixeira L, Tabone O, Graham CM, Singhania A, Stavropoulos E, Redford PS, et al. Mouse transcriptome reveals potential signatures of protection and pathogenesis in human tuberculosis. Nature Immunology 2020;21(4):464–76. https://doi.org/10.1038/s41590-020-0610-z.
Perez-Recio S, Pallares N, Grijota-Camino MD, Sanchez-Montalva A, Barcia L, Campos-Guti´errez S, et al. Identification of recent tuberculosis exposure using QuantiFERON-TB Gold Plus, a multicenter study. Microbiology Spectrum 2021;9. https://doi.org/10.1128/SPECTRUM.00972-21
How to Cite

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.